Radiopharmaceuticals are attracting major investment across the life sciences industry, but what are they, how do they work, and why do they matter? Steve Vinson explains how these medicines combine a targeting molecule with a radioactive isotope to help physicians identify disease or deliver radiation directly...

In this solo episode of The Life Science Effect, Steve Vinson reflects on a recent AI panel discussion hosted by the ISPE Great Lakes Chapter at Endress+Hauser in Greenwood, Indiana. Drawing from conversations with industry experts spanning automation, validation, compliance, CDMOs, and workforce transformation,...

In this solo episode, Steve Vinson explores the rapidly evolving obesity drug market, highlighting insights from a recent Fierce Biotech power rankings article. He breaks down why Lilly and Novo Nordisk currently dominate, while examining the growing competitive field and what may determine the next wave of winners....

In this episode, Steve Vinson examines the sustained wave of biopharma manufacturing investment in North America and challenges the idea that tariffs were the primary driver. He explores the deeper forces reshaping the industry, including supply chain resilience, demand for complex biologics, and global...